Getinge AB (publ) (GNGBY) Stock

About Getinge AB (publ)

Getinge AB (publ) is a prominent global medical technology provider, delivering comprehensive products and solutions primarily to operating rooms, intensive care units, and sterilization departments. The company operates through three distinct segments: Acute Care Therapies, Life Science, and Surgical Workflows. Its extensive product portfolio for sterile environments includes advanced transfer systems, closure processing systems, washers, isolators, sterilizers, and automated logistic solutions. For the life sciences sector, Getinge offers bioreactors, bioprocess control systems, software, biobundles, analytics, and perfusion systems. Within acute care and surgical settings, offerings span anesthesia machines, patient monitoring systems and disposables, and specialized cardiac surgery tools like beating heart stabilizers and coronary shunts. This segment also provides ceiling supply units, integrated digital solutions, and various cleaning, disinfection, packaging, and sealing products, including its SteriTec range. Further extending its medical device offerings, Getinge supplies a wide array of specialized items such as thoracic catheters, diverse chest drain systems, and related accessories. The portfolio also covers endoscope reprocessing, endoscopic vessel harvesting, endovascular products, and critical extracorporeal life support (ECMO) and intra-aortic balloon pump therapies. Additional provisions include mechanical ventilation, medical furniture, modular room systems, state-of-the-art operating lights and tables, comprehensive OR integration and management solutions, patient flow management systems, and solutions for patient transport, sterile supply management, surgical assist, and surgical perfusion, alongside vascular and cardiothoracic surgery solutions. Getinge distributes its products and solutions globally through a robust network that includes proprietary sales companies, agents, and distributors. This network spans the Americas, Europe, the Middle East, Africa, and the Asia Pacific regions. Founded in 1904, Getinge AB (publ) maintains its corporate headquarters in Gothenburg, Sweden.

Getinge AB (publ) is headquartered in SE.

Getinge AB (publ) (GNGBY) stock trades at $23.97 with a market capitalization of $6.53B. The stock is valued at a price-to-earnings (P/E) ratio of 23.72, price-to-book of 2.05, price-to-sales of 1.86. Over the past 52 weeks the stock has ranged between $18.99 and $24.67, and currently trades 2.8% below its 52-week high. It pays a dividend yielding 2.13%.

On profitability, Getinge AB (publ) generates a return on equity (ROE) of 8.88%, return on capital employed of 10.24%, an operating margin of 13.56%, a net profit margin of 7.82%.

Official website: www.getinge.com

Getinge AB (publ) by the numbers, 2016–2025

Between 2016 and 2025 Getinge AB (publ) reported revenue of $29.8B rising to $35.0B, a change of +17.5% across 10 years. Compounded, revenue has grown 3.2% a year over five years, 7.3% over three, 0.6% over the last twelve months. Net profit rose to $2.3B.

Operating margin went from 7.7% in 2016 to 10.8% in 2025, a gain of 3.1 percentage points. The most recent net margin is 7.82%. On a trailing twelve-month basis to Jun '26, revenue is $34.1B and net profit $2.7B.

Borrowings fell from $21.7B to $10.9B, cash on hand is $2.1B, cash from operations was $3.9B in the latest year, positive in 10 of the last 10.

Return on equity has averaged 8.2% over five years, and was 7.7% in the most recent year.

The share price itself has compounded at -8.5% a year over five years, 11.8% over three, 23.6% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Getinge AB (publ) (GNGBY) — frequently asked questions